Table 2.
Area Under the Receiver Operating Characteristic Curve Values for Fracture Risk Assessment Tool (FRAX) Alone and FRAX with Additional Clinical Characteristics on Predicted 10‐Year Risk of Fracture
Hip fracture | Major osteoporotic fracture | |||
---|---|---|---|---|
Modela | n | AUC (95% CI) | n | AUC (95% CI) |
All participants | ||||
Age | 92,075 | 77.1 (76.0–78.2) | 94,413 | 64.7 (64.1–65.2) |
Age + BMI | 92,075 | 77.4 (76.3–78.4) | 94,413 | 64.6 (64.1–65.2) |
Age + history of fracture (any site) | 92,075 | 77.1 (76.1–78.2) | 94,413 | 65.2 (64.6–65.7) |
FRAX alone (all participants) | 92,075 | 76.2 (75.1–77.3) | 94,413 | 65.0 (64.5–65.6) |
FRAX alone (white participants) | 79,909 | 75.4 (74.3–76.6) | 81,947 | 64.2 (63.6–64.8) |
FRAX alone (black participants) | 6194 | 81.2 (74.5–88.0) | 6903 | 60.6 (57.5–63.7) |
FRAX + treated diabetes | 92,075 | 76.5 (75.4–77.5) | 94,413 | 65.3 (64.8–65.9) |
FRAX + ≥2 falls in the past year | 92,075 | 75.4 (74.3–76.5) | 94,413 | 65.3 (64.8–65.9) |
FRAX + vasomotor symptoms | 92,075 | 74.8 (73.6–76.0) | 94,413 | 65.0 (64.4–65.5) |
FRAX + physical function | 92,075 | 75.9 (74.9–77.0) | 94,413 | 66.2 (65.6–66.7) |
FRAX + all additional factors | 92,075 | 76.2 (75.1–77.3) | 94,413 | 66.6 (66.0–67.1) |
BMD subset | ||||
Age | 5541 | 76.1 (72.1–80.2) | 5722 | 66.2 (64.1–68.3) |
Age + BMI | 5541 | 76.3 (72.2–80.4) | 5722 | 66.2 (64.1–68.3) |
Age + history of fracture (any site) | 5541 | 76.4 (72.5–80.4) | 5722 | 67.4 (65.3–69.5) |
FRAX alone (all participants) | 5541 | 77.6 (73.7–81.5) | 5722 | 69.8 (67.8–71.8) |
FRAX alone (white participants) | 4537 | 77.0 (72.8–81.1) | 4695 | 68.3 (66.1–70.5) |
FRAX alone (black participants) | 663 | 84.5 (69.2–99.9) | 672 | 65.6 (55.6–75.6) |
FRAX + treated diabetes | 5541 | 77.2 (73.1–81.2) | 5722 | 70.2 (68.2–72.1) |
FRAX + ≥2 falls in the past year | 5541 | 76.6 (72.6–80.7) | 5722 | 70.0 (68.0–72.0) |
FRAX + vasomotor symptoms | 5541 | 76.4 (72.1–80.7) | 5722 | 69.8 (67.8–71.8) |
FRAX + physical function | 5541 | 77.3 (73.4–81.2) | 5722 | 70.7 (68.7–72.7) |
FRAX + lumbar spine BMD | 5541 | 75.9 (71.7–80.1) | 5722 | 70.0 (68.0–71.9) |
FRAX + all additional factors | 5541 | 77.7 (73.4–81.9) | 5722 | 71.4 (69.4–73.4) |
All models are adjusted for intervention assignment in the WHI Hormone (Active, Placebo, not Randomized) and Calcium Vitamin D (Active, Placebo, Not Randomized) trials.